Antihypertensive drugs and incidence of dementia: the Rotterdam Study

被引:196
|
作者
Veld, BAI
Ruitenberg, A
Hofman, A
Stricker, BHC
Breteler, MMB [1 ]
机构
[1] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[2] Inspectorate Hlth Care, Drug Safety Unit, The Hague, Netherlands
关键词
dementia; Alzheimer's disease; antihypertensives; cohort study; epidemiology;
D O I
10.1016/S0197-4580(00)00241-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
There is increasing evidence that hypertension may contribute to the development of dementia. We investigated the relation of antihypertensive drug use and the risk of dementia in the cohort of the population based Rotterdam Study. The study cohort included 7046 elderly, free of dementia at baseline. Dementia was diagnosed in a stepwise procedure. Participants were first screened. Screen positives were further tested. Those suspected of dementia underwent a diagnostic work-up. Dementia and its subtypes were diagnosed according to prevailing criteria. A Cox proportional hazards model was used to estimate relative risks. After a mean follow-up of 2.2 years, subjects taking antihypertensive medication at baseline (n = 2015) had a reduced incidence of dementia (adjusted relative risk, 0.76; 95% confidence interval 0.52-1.12). This risk reduction was most pronounced for vascular dementia, (adjusted relative risk, 0.30; 95% confidence interval 0.11-0.99). For Alzheimer's disease the relative risk was 0.87, not significant. Dementia may be prevented by antihypertensive treatment. In order to confirm any relation in Alzheimer's disease larger observational studies with longer follow-up are needed. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [21] Association of diabetes mellitus and dementia: The Rotterdam study
    Ott, A
    Stolk, RP
    Hofman, A
    vanHarskamp, F
    Grobbee, DE
    Breteler, MMB
    DIABETOLOGIA, 1996, 39 (11) : 1392 - 1397
  • [22] ATRIAL-FIBRILLATION AND DEMENTIA - THE ROTTERDAM STUDY
    BRETELER, MMB
    MOSTERD, A
    GROBBEE, DE
    HOFMAN, A
    NEUROLOGY, 1994, 44 (04) : A297 - A298
  • [23] Vitamin D and the Risk of Dementia: The Rotterdam Study
    Licher, Silvan
    de Bruijn, Renee F. A. G.
    Wolters, Frank J.
    Zillikens, M. Carola
    Ikram, M. Arfan
    Ikram, M. Kamran
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (03) : 989 - 997
  • [24] Thyroid status and the risk of dementia: The Rotterdam study
    Kalmijn, S
    Mehta, KM
    Pols, HAP
    Hofman, A
    Drexhage, HA
    Breteler, MMB
    NEUROLOGY, 1999, 52 (06) : A434 - A434
  • [25] The new epidemic: Frequency of dementia in the Rotterdam study
    Breteler, MMB
    Ott, A
    Hofman, A
    HAEMOSTASIS, 1998, 28 (3-4) : 117 - 123
  • [26] Fibrinogen and the risk of dementia. The Rotterdam Study
    Breteler, MMB
    Ott, A
    Hofman, A
    NEUROLOGY, 1997, 48 (03) : 57004 - 57004
  • [27] Diabetes mellitus and the risk of dementia - The Rotterdam Study
    Ott, A
    Stolk, RP
    van Harskamp, F
    Pols, HAP
    Hofman, A
    Breteler, MMB
    NEUROLOGY, 1999, 53 (09) : 1937 - 1942
  • [28] Thyroid function and the risk of dementia The Rotterdam Study
    Chaker, Layal
    Wolters, Frank J.
    Bos, Daniel
    Korevaar, Tim I. M.
    Hofman, Albert
    van der Lugt, Aad
    Koudstaal, Peter J.
    Franco, Oscar H.
    Dehghan, Abbas
    Vernooij, Meike W.
    Peeters, Robin P.
    Ikram, M. Arfan
    NEUROLOGY, 2016, 87 (16) : 1688 - 1695
  • [29] Alcohol consumption and risk of dementia: the Rotterdam Study
    Ruitenberg, A
    van Swieten, JC
    Witteman, JCM
    Mehta, KM
    van Duijn, CM
    Hofman, A
    Breteler, MMB
    LANCET, 2002, 359 (9303): : 281 - 286
  • [30] Incidence of Cerebral Microbleeds in the Rotterdam Scan Study
    Poels, Marielle M.
    Ikram, M. A.
    van der Lugt, Aad
    Hofman, Albert
    Krestin, Gabriel P.
    Breteler, Monique M.
    Vernooij, Meike W.
    STROKE, 2011, 42 (03) : E59 - E59